Immunologic approaches to the management of ovarian carcinoma.
D000911:Antibodies, Monoclonal / Q000276:immunology; D000920:Antibody-Dependent Cell Cytotoxicity; D000936:Antigen-Antibody Complex / Q000032:analysis; D000951:Antigens, Neoplasm / Q000032:analysis; D001500:BCG Vaccine / Q000627:therapeutic use; D005260:Female; D006801:Humans; D007116:Immunization, Passive; D007167:Immunotherapy; D007372:Interferons / Q000627:therapeutic use; D007978:Levamisole / Q000627:therapeutic use; D010051:Ovarian Neoplasms / Q000276:immunology* / Q000628:therapy; D011425:Propionibacterium acnes / Q000276:immunology
D000911:Antibodies, Monoclonal; D000936:Antigen-Antibody Complex; D000951:Antigens, Neoplasm; D001500:BCG Vaccine; C020163:blocking factor; C017589:ovarian tumor associated antigen; D007978:Levamisole; D007372:Interferons